Home › Companies › LARIMAR THERAPEUTICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and LARIMAR THERAPEUTICS INC.’s Form 8-K, filed May 13, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of May 13, 2025: 3 items on LARIMAR THERAPEUTICS INC.’s Form 8-K, filed May 13, 2025: 1 elected · 2 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore LARIMAR THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are LARIMAR THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 13, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Thomas E. Hamilton | 46,479,322 | -- | -- | 4,326,129 | 6,865,481 | 91% | Elected | — |
| 2. Approval, on an advisory basis, of the compensation of the Company's named executive officers in 2024 | 49,187,132 | 1,445,631 | 172,688 | -- | 6,865,481 | 97% | Approved | — |
| 3. Ratification of Independent Registered Public Accountant | 57,657,322 | 10,851 | 2,759 | -- | 0 | 99.9% | Approved | — |
Source: LARIMAR THERAPEUTICS INC., Form 8-K, filed with the SEC on May 13, 2025 — read the filing on EDGAR.
Each item below shows how the 108 asset managers that disclosed a LARIMAR THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
91% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF CLASS II DIRECTOR FOR A THREE-YEAR TERM EXPIRING IN 2028: THOMAS E. HAMILTON
LARIMAR THERAPEUTICS INC.’s own tally for this item (“Elect Director: Thomas E. Hamilton”): 46,479,322 for, 4,326,129 withheld, per its Form 8-K filed May 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Thomas E. Hamilton was elected to the Board of Directors of the Company as a Class II director to serve until the Company's 2028 Annual Meeting of Stockholders and until his successor, if any, is duly elected and qualified or appointed, or his earlier death, resignation, or removal, as follows:”
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 36 asset managers below reported 3,906,122 for, 826,451 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,587,956 | 0 | 0 | 37,029 | For |
| Vanguard | 1,494,271 | 0 | 0 | 0 | For |
| Fidelity | 692,304 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 164,215 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 100,457 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 96,916 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 70,068 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 63,904 | Withhold |
| Equitable | 23,314 | 0 | 0 | 33,060 | Mixed |
| ALPS ETF Trust | 0 | 0 | 0 | 48,282 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 31,200 | Withhold |
| ETFis Series Trust I | 0 | 0 | 0 | 26,869 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 26,037 | Withhold |
| Global X | 0 | 0 | 0 | 25,209 | Withhold |
| Northern Trust | 0 | 0 | 0 | 22,360 | Withhold |
| Dimensional | 0 | 0 | 0 | 21,565 | Withhold |
| Nationwide | 11,509 | 0 | 0 | 9,544 | Mixed |
| AIG/SunAmerica | 0 | 0 | 0 | 20,609 | Withhold |
| John Hancock | 0 | 0 | 0 | 16,157 | Withhold |
| State Street | 0 | 0 | 0 | 15,923 | Withhold |
| Pacific Life | 14,574 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 12,761 | Withhold |
| Voya | 0 | 0 | 0 | 12,092 | Withhold |
| Bridge Builder Trust | 8,134 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 0 | 6,900 | Withhold |
Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.
Combines 3 wordings of this item as funds reported it.
97% Approved · of votes cast
Description as filed by funds: APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS IN 2024
LARIMAR THERAPEUTICS INC.’s own tally for this item (“2. Approval, on an advisory basis, of the compensation of the Company's named executive officers in 2024”): 49,187,132 for, 1,445,631 against — passed, per its Form 8-K filed May 13, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders approved, on an advisory basis, the compensation of the Company's named executive officers in 2024, as follows:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,624,985 | 0 | 0 | 0 | For |
| Vanguard | 1,494,271 | 0 | 0 | 0 | For |
| Fidelity | 692,304 | 0 | 0 | 0 | For |
| TIAA | 164,215 | 0 | 0 | 0 | For |
| Charles Schwab | 100,457 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 96,916 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 70,068 | 0 | 0 | 0 | For |
| American Century | 0 | 63,904 | 0 | 0 | Against |
| Equitable | 56,374 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 48,282 | 0 | 0 | 0 | For |
| Lincoln Financial | 31,200 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 26,869 | 0 | 0 | 0 | For |
| Goldman Sachs | 26,037 | 0 | 0 | 0 | For |
| Global X | 25,209 | 0 | 0 | 0 | For |
| Northern Trust | 22,360 | 0 | 0 | 0 | For |
| Dimensional | 21,565 | 0 | 0 | 0 | For |
| Nationwide | 21,053 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 20,609 | 0 | 0 | 0 | For |
| John Hancock | 16,157 | 0 | 0 | 0 | For |
| State Street | 15,923 | 0 | 0 | 0 | For |
| Pacific Life | 14,574 | 0 | 0 | 0 | For |
| ProShares | 12,761 | 0 | 0 | 0 | For |
| Voya | 12,092 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 8,134 | 0 | 0 | 0 | For |
| SEI | 6,900 | 0 | 0 | 0 | For |
Fund voting reports, all 36 managers: 4,567,632 for, 164,941 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. | 21,231,974 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 5,709,058 | 0 | 0 | 0 | For |
| Janus Henderson | 4,820,042 | 0 | 0 | 0 | For |
| Blue Owl Capital Holdings LP | 4,753,040 | 0 | 0 | 0 | For |
| BlackRock | 1,049,198 | 129 | 0 | 0 | For |
| Goldman Sachs | 904,593 | 0 | 0 | 0 | For |
| Alyeska Investment Group, L.P. | 0 | 850,631 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 765,092 | 0 | 0 | 0 | For |
| Woodline Partners LP | 622,682 | 0 | 0 | 0 | For |
| State Street | 606,059 | 181 | 0 | 0 | For |
| Opaleye Management Inc. | 550,000 | 0 | 0 | 0 | For |
| Citadel | 459,283 | 0 | 0 | 0 | For |
| DAFNA Capital Management LLC | 371,434 | 0 | 0 | 0 | For |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 355,995 | 0 | 0 | 0 | For |
| Point72 | 254,384 | 0 | 0 | 0 | For |
| Northern Trust | 208,625 | 0 | 0 | 0 | For |
| Two Sigma | 204,565 | 0 | 0 | 0 | For |
| Nuveen | 174,788 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 138,965 | 0 | 0 | 0 | For |
| UBS | 138,602 | 0 | 0 | 0 | For |
| Renaissance | 106,908 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 103,216 | 0 | 0 | Against |
| Charles Schwab | 100,457 | 0 | 0 | 0 | For |
| STATE OF WISCONSIN INVESTMENT BOARD | 87,527 | 0 | 0 | 0 | For |
| American Century | 0 | 63,904 | 0 | 0 | Against |
Institutional-manager reports, all 86 managers: 43,966,004 for, 1,068,225 against, 137 not voted. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: Ratification of Appointment of PricewaterhouseCoopers LLP as our Independent Registered Public Accounting Firm for the 2025 Fiscal Year
LARIMAR THERAPEUTICS INC.’s own tally for this item (“3. Ratification of Independent Registered Public Accountant”): 57,657,322 for, 10,851 against — passed, per its Form 8-K filed May 13, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the 2025 fiscal year was ratified, as follows:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 36 asset managers below reported 4,732,573 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,624,985 | 0 | 0 | 0 | For |
| Vanguard | 1,494,271 | 0 | 0 | 0 | For |
| Fidelity | 692,304 | 0 | 0 | 0 | For |
| TIAA | 164,215 | 0 | 0 | 0 | For |
| Charles Schwab | 100,457 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 96,916 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 70,068 | 0 | 0 | 0 | For |
| American Century | 63,904 | 0 | 0 | 0 | For |
| Equitable | 56,374 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 48,282 | 0 | 0 | 0 | For |
| Lincoln Financial | 31,200 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 26,869 | 0 | 0 | 0 | For |
| Goldman Sachs | 26,037 | 0 | 0 | 0 | For |
| Global X | 25,209 | 0 | 0 | 0 | For |
| Northern Trust | 22,360 | 0 | 0 | 0 | For |
| Dimensional | 21,565 | 0 | 0 | 0 | For |
| Nationwide | 21,053 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 20,609 | 0 | 0 | 0 | For |
| John Hancock | 16,157 | 0 | 0 | 0 | For |
| State Street | 15,923 | 0 | 0 | 0 | For |
| Pacific Life | 14,574 | 0 | 0 | 0 | For |
| ProShares | 12,761 | 0 | 0 | 0 | For |
| Voya | 12,092 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 8,134 | 0 | 0 | 0 | For |
| SEI | 6,900 | 0 | 0 | 0 | For |
Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 64,027,892 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 2.54% |
| 2 | Vanguard | 2.33% |
| 3 | Fidelity | 1.08% |
| 4 | TIAA | 0.26% |
| 5 | Charles Schwab | 0.16% |
| 6 | BRIDGEWAY FUNDS INC | 0.15% |
| 7 | QUANTITATIVE MASTER SERIES LLC | 0.11% |
| 8 | American Century | 0.10% |
| 9 | Equitable | 0.09% |
| 10 | ALPS ETF Trust | 0.08% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | DEERFIELD MANAGEMENT COMPANY, L.P. | 33.16% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 8.92% |
| 3 | Janus Henderson | 7.53% |
| 4 | Blue Owl Capital Holdings LP | 7.42% |
| 5 | BlackRock | 1.64% |
| 6 | Goldman Sachs | 1.41% |
| 7 | Alyeska Investment Group, L.P. | 1.33% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 1.19% |
| 9 | Woodline Partners LP | 0.97% |
| 10 | State Street | 0.95% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Deerfield Management Company, L.P. | 55.71% | 13D |
| Opaleye Management, Inc. | 6.42% | 13G |
| BlackRock | 4.88% | 13F |
| Goldman Sachs | 4.17% | 13F |
| Vanguard Group | 3.46% | 13F |
| Renaissance Technologies | 1.52% | 13F |
| Geode Capital | 1.42% | 13F |
| State Street | 1.30% | 13F |
| Millennium Management | 1.05% | 13F |
| Citadel Advisors | 0.78% | 13F |
Percentages above are of 64,027,892 shares outstanding, as reported by LARIMAR THERAPEUTICS INC. on its Form 10-Q dated April 27, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from LARIMAR THERAPEUTICS INC.’s 10-Q dated April 27, 2025. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At LARIMAR THERAPEUTICS INC.'s shareholder meeting held May 13, 2025, in the 2024-2025 proxy season, 108 asset managers reported how they voted on 3 ballot items in their SEC Form N-PX filings, covering 409 separate fund positions. On the most widely held item on that ballot — APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS IN 2024 — LARIMAR THERAPEUTICS INC.'s filing reports the proposal as approved, with 97% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: LARIMAR THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 13, 2025.
LARIMAR THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.